Baxter International Inc. (BAX)

75.03
NYSE : Health Technology
Prev Close 75.57
Day Low/High 74.50 / 75.52
52 Wk Low/High 61.05 / 82.25
Avg Volume 2.83M
Exchange NYSE
Shares Outstanding 510.17M
Market Cap 38.55B
EPS 3.00
P/E Ratio 25.70
Div & Yield 0.88 (1.01%)

Latest News

Baxter Increases Dividend And Declares Quarterly Dividend

Baxter Increases Dividend And Declares Quarterly Dividend

Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced an increase in the company's quarterly cash dividend, to a rate of $0.

Baxter To Present At The UBS Global Healthcare Conference

Baxter To Present At The UBS Global Healthcare Conference

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the UBS Global Healthcare Conference on Monday, May 20, 2019 in New York.

Baxter, NAACP And The Alliance For Home Dialysis Expand Program To Increase Awareness Of Kidney Care Among African Americans

Baxter, NAACP And The Alliance For Home Dialysis Expand Program To Increase Awareness Of Kidney Care Among African Americans

Baxter International Inc. (NYSE:BAX), a global leader in renal care, along with the National Association for the Advancement of Colored People (NAACP) and the Alliance for Home Dialysis, today announced that the Dialysis Health Imperative for Access,...

Baxter Reports First-Quarter 2019 Results

Baxter Reports First-Quarter 2019 Results

Baxter International Inc. (NYSE:BAX), a leading global medical products company, today reported results for the first quarter of 2019 and increased its full-year 2019 earnings outlook.

Baxter To Present At The Bank Of America Merrill Lynch Health Care Conference 2019

Baxter To Present At The Bank Of America Merrill Lynch Health Care Conference 2019

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the 2019 Bank of America Merrill Lynch Health Care Conference in Las Vegas on May 15, 2019.

Baxter Unveils The Latest Evolution Of Floseal At AORN Meeting

Baxter Unveils The Latest Evolution Of Floseal At AORN Meeting

Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced that it has received U.

Baxter To Host Webcast Of Annual Meeting Of Stockholders

Baxter To Host Webcast Of Annual Meeting Of Stockholders

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will host a webcast of its Annual Meeting of Stockholders on Tuesday, May 7, 2019 at 9 a.

Baxter Highlights Advancements In Clinical Nutrition At ASPEN Conference

Baxter Highlights Advancements In Clinical Nutrition At ASPEN Conference

Baxter International Inc. (NYSE:BAX), a global leader in clinical nutrition, today announced it will launch Clinolipid (20% Lipid Injectable Emulsion), its proprietary olive oil-based lipid emulsion, in the U.

Baxter To Host First Quarter 2019 Financial Results Conference Call For Investors

Baxter To Host First Quarter 2019 Financial Results Conference Call For Investors

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will host a conference call to discuss its first quarter 2019 financial results on Thursday, April 25, 2019, at 7:30 a.

Baxter Announces U.S. FDA Approval And Launch Of Ready-to-Use Cardiovascular Medicine Eptifibatide

Baxter Announces U.S. FDA Approval And Launch Of Ready-to-Use Cardiovascular Medicine Eptifibatide

Baxter International Inc. (NYSE:BAX), a global leader in sterile medication production and delivery, today announced the U.

Baxter Honored As A 2019 "Top Company For Executive Women" By The National Association For Female Executives

Baxter Honored As A 2019 "Top Company For Executive Women" By The National Association For Female Executives

Baxter International Inc. (NYSE:BAX), a leading global medical products company, announced today that it has been named one of the 2019 NAFE Top Companies for Executive Women by the National Association for Female Executives (NAFE).

Baxter Declares Quarterly Dividend

Baxter Declares Quarterly Dividend

Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced that its Board of Directors has declared a quarterly cash dividend of $0.

Baxter To Present At The Barclays Global Healthcare Conference

Baxter To Present At The Barclays Global Healthcare Conference

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the Barclays Global Healthcare Conference in Miami, Fla.

Baxter To Present At The Raymond James 40th Annual Institutional Investors Conference

Baxter To Present At The Raymond James 40th Annual Institutional Investors Conference

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the Raymond James 40th Annual Institutional Investors Conference in Orlando, Fla.

Baxter Reports 2018 Fourth-Quarter And Full-Year Results

Baxter Reports 2018 Fourth-Quarter And Full-Year Results

Baxter International Inc. (NYSE:BAX), a leading global medical products company, today reported results for the fourth quarter and full year ended Dec.

Baxter To Present At The 8th Annual SVB Leerink Global Healthcare Conference

Baxter To Present At The 8th Annual SVB Leerink Global Healthcare Conference

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the 8th Annual SVB Leerink Global Healthcare Conference in New York, NY on Thursday, February 28, 2019.

Baxter's Sharesource Remote Patient Management Platform Has Logged More Than 5 Million Home Peritoneal Dialysis Treatments Globally; Milestone Is Evidence That Smarter, More Effective Innovation Is Enhancing Renal Care. (Photo: Business Wire)

Baxter's Sharesource Remote Patient Management Platform Has Logged More Than 5 Million Home Peritoneal Dialysis Treatments Globally; Milestone Is Evidence That Smarter, More Effective Innovation Is Enhancing Renal Care. (Photo: Business Wire)

Baxter International Inc. (NYSE:BAX), a global innovator in renal care, announced the Sharesource remote patient management platform has performed more than 5 million home peritoneal dialysis (PD) treatments globally.

Baxter Has Started The U.S. Clinical Trial For Its Latest Peritoneal Dialysis Technology Designed To Generate Solution On Demand In Homes.

Baxter Has Started The U.S. Clinical Trial For Its Latest Peritoneal Dialysis Technology Designed To Generate Solution On Demand In Homes.

Baxter International Inc. (NYSE:BAX), a global innovator in renal care, announced today that the first patients have been enrolled in a U.

Baxter To Host Fourth Quarter 2018 Financial Results Conference Call For Investors

Baxter To Host Fourth Quarter 2018 Financial Results Conference Call For Investors

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will host a conference call to discuss its fourth quarter 2018 financial results on Thursday, January 31, 2019, at 7:30 a.

Baxter Launches Curved Applicator For Floseal, Expanding Use Of Leading Hemostat During ENT Procedures

Baxter Launches Curved Applicator For Floseal, Expanding Use Of Leading Hemostat During ENT Procedures

Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced the introduction of the Disposable Curved Applicator, which enhances the delivery experience of its Floseal Hemostatic Matrix product line for...

Baxter Supports New EFCNI Standards In Newborn Care In Raising Awareness Of Risks From Malnutrition

Baxter Supports New EFCNI Standards In Newborn Care In Raising Awareness Of Risks From Malnutrition

Baxter International Inc. (NYSE:BAX), a global leader in clinical nutrition, is collaborating with the European Foundation for the Care of Newborn Infants (EFCNI) to raise awareness for the new EFCNI standards that address the disparities in newborn care...

Baxter Appoints Patricia Morrison And Amy Wendell To Its Board

Baxter Appoints Patricia Morrison And Amy Wendell To Its Board

Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced it has appointed Patricia B.

Baxter To Present At The 37th Annual J.P. Morgan Healthcare Conference

Baxter To Present At The 37th Annual J.P. Morgan Healthcare Conference

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the 37th Annual J.

Baxter Unveils New Products At The ASMBS - Obesity Week Meeting To Help Surgeons Overcome Challenges During Bariatric Surgery

Baxter Unveils New Products At The ASMBS - Obesity Week Meeting To Help Surgeons Overcome Challenges During Bariatric Surgery

Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, revealed its Peri-Strips Dry with Veritas (PSDV) Circular Staple Line Reinforcement with Secure Grip technology, the latest evolution in a product portfolio that has...

Baxter Declares Quarterly Dividend And Announces Expanded Share Repurchase Authorization

Baxter Declares Quarterly Dividend And Announces Expanded Share Repurchase Authorization

Baxter International Inc. (NYSE:BAX), a leading global medical products company, announced today a quarterly cash dividend and an expanded authorization for its share repurchase program.

Baxter Highlights Data At ISPOR Europe 2018 On Clinical And Economic Benefits When Addressing Malnutrition, Intraoperative Bleeding

Baxter Highlights Data At ISPOR Europe 2018 On Clinical And Economic Benefits When Addressing Malnutrition, Intraoperative Bleeding

Baxter International Inc. (NYSE:BAX), a leading global medical products company, is presenting four health economics and outcomes research (HEOR) analyses this week at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Europe...

Baxter Introduces New Tisseel Prima Syringe At 2018 American Association Of Gynecologic Laparoscopists Meeting

Baxter Introduces New Tisseel Prima Syringe At 2018 American Association Of Gynecologic Laparoscopists Meeting

Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today unveiled the latest design enhancements for its fibrin sealant product, the Tisseel Prima syringe, at the 2018 American Association of Gynecologic Laparoscopists...

TheStreet Quant Rating: B+ (Buy)